XML 68 R59.htm IDEA: XBRL DOCUMENT v3.25.3
Impairment of Intangible Assets (Details) - EUR (€)
€ in Millions
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
 [2]
Disclosure of detailed information about intangible assets [line items]    
Impairment loss on other intangible assets [1] € 210 € (371)
Other intangible assets [member]    
Disclosure of detailed information about intangible assets [line items]    
Impairment loss on other intangible assets € 210  
[1] These unaudited condensed half year consolidated financial statements as of June 30, 2025 should be read in conjunction with Sanofi’s audited consolidated financial statements as of December 31, 2024.
[2] Figures for the 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.